Results 151 to 160 of about 797,280 (374)
Molecular Oncology, EarlyView.B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez +17 more
wiley +1 more source
"Research Questions?" Mugar Library posters [PDF]
, 2017 This poster was created to make BU students aware of library ...
Monroe, Katherine
core
Ubiquitination of transcription factors in cancer: unveiling therapeutic potential
Molecular Oncology, EarlyView.In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley +1 more source
"Read for pleasure" Mugar Greene Scholars posters [PDF]
, 2017 These posters were created by the Mugar Greene Scholars to promote reading for ...
Yang, Hanna
core
Safer Sex und Solidarität. Die Sammlung internationaler Aidsplakate im Deutschen Hygiene-Museum
Zeithistorische Forschungen, 2013 Susanne Roeßiger
doaj +1 more source
Intracellular localization of precipitates, probably calcium ions, in gall nutritive cells (POSTER) [PDF]
, 1980 Roberte Bronner
openalex +1 more source
Molecular Oncology, EarlyView.Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen +12 more
wiley +1 more source